vs
BrightSpire Capital, Inc.（BRSP）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
BrightSpire Capital, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$83.2M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -17.3%，领先401.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -0.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -6.8%）
该公司是英国大型投资信托，专注投资于商业服务、消费、教育与科技领域的中型市场企业，在伦敦证券交易所上市，是富时250指数的成份股。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BRSP vs RIGL — 直观对比
营收规模更大
BRSP
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出21.6%
-0.4%
净利率更高
RIGL
高出401.3%
-17.3%
两年增速更快
RIGL
近两年复合增速
-6.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.2M | $69.8M |
| 净利润 | $-14.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | -17.3% | 384.0% |
| 营收同比 | -0.4% | 21.2% |
| 净利润同比 | 27.3% | 1769.2% |
| 每股收益（稀释后） | $-0.11 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRSPRIGL
| Q4 25 | $83.2M | $69.8M | ||
| Q3 25 | $83.9M | $69.5M | ||
| Q2 25 | $85.9M | $101.7M | ||
| Q1 25 | $77.6M | $53.3M | ||
| Q4 24 | $83.5M | $57.6M | ||
| Q3 24 | $88.2M | $55.3M | ||
| Q2 24 | $91.4M | $36.8M | ||
| Q1 24 | $95.8M | $29.5M |
净利润BRSPRIGL
| Q4 25 | $-14.4M | $268.1M | ||
| Q3 25 | $984.0K | $27.9M | ||
| Q2 25 | $-23.1M | $59.6M | ||
| Q1 25 | $5.3M | $11.4M | ||
| Q4 24 | $-19.7M | $14.3M | ||
| Q3 24 | $12.7M | $12.4M | ||
| Q2 24 | $-67.9M | $-1.0M | ||
| Q1 24 | $-57.1M | $-8.2M |
毛利率BRSPRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率BRSPRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | -1.7% | 40.9% | ||
| Q2 25 | -54.5% | 60.1% | ||
| Q1 25 | 5.1% | 23.9% | ||
| Q4 24 | -24.9% | 28.9% | ||
| Q3 24 | 13.2% | 25.4% | ||
| Q2 24 | -74.9% | 1.2% | ||
| Q1 24 | -59.4% | -23.6% |
净利率BRSPRIGL
| Q4 25 | -17.3% | 384.0% | ||
| Q3 25 | 1.2% | 40.2% | ||
| Q2 25 | -26.9% | 58.6% | ||
| Q1 25 | 6.9% | 21.5% | ||
| Q4 24 | -23.7% | 24.9% | ||
| Q3 24 | 14.4% | 22.5% | ||
| Q2 24 | -74.2% | -2.8% | ||
| Q1 24 | -59.6% | -27.9% |
每股收益（稀释后）BRSPRIGL
| Q4 25 | $-0.11 | $14.11 | ||
| Q3 25 | $0.00 | $1.46 | ||
| Q2 25 | $-0.19 | $3.28 | ||
| Q1 25 | $0.04 | $0.63 | ||
| Q4 24 | $-0.16 | $0.82 | ||
| Q3 24 | $0.09 | $0.70 | ||
| Q2 24 | $-0.53 | $-0.06 | ||
| Q1 24 | $-0.45 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.8M | $155.0M |
| 总债务越低越好 | $2.5B | $52.5M |
| 股东权益账面价值 | $938.4M | $391.5M |
| 总资产 | $3.6B | $513.6M |
| 负债/权益比越低杠杆越低 | 2.63× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BRSPRIGL
| Q4 25 | $66.8M | $155.0M | ||
| Q3 25 | $113.4M | $137.1M | ||
| Q2 25 | $154.3M | $108.4M | ||
| Q1 25 | $200.9M | $77.1M | ||
| Q4 24 | $302.2M | $77.3M | ||
| Q3 24 | $263.8M | $61.1M | ||
| Q2 24 | $203.3M | $49.1M | ||
| Q1 24 | $221.5M | $49.5M |
总债务BRSPRIGL
| Q4 25 | $2.5B | $52.5M | ||
| Q3 25 | $2.2B | $60.0M | ||
| Q2 25 | $2.3B | $60.0M | ||
| Q1 25 | $2.3B | $60.0M | ||
| Q4 24 | $2.5B | $60.0M | ||
| Q3 24 | $2.6B | $60.0M | ||
| Q2 24 | $2.5B | $60.0M | ||
| Q1 24 | $2.6B | $60.0M |
股东权益BRSPRIGL
| Q4 25 | $938.4M | $391.5M | ||
| Q3 25 | $976.4M | $117.6M | ||
| Q2 25 | $994.4M | $81.9M | ||
| Q1 25 | $1.0B | $18.6M | ||
| Q4 24 | $1.0B | $3.3M | ||
| Q3 24 | $1.1B | $-14.6M | ||
| Q2 24 | $1.1B | $-29.9M | ||
| Q1 24 | $1.2B | $-31.7M |
总资产BRSPRIGL
| Q4 25 | $3.6B | $513.6M | ||
| Q3 25 | $3.3B | $242.5M | ||
| Q2 25 | $3.4B | $206.7M | ||
| Q1 25 | $3.6B | $176.0M | ||
| Q4 24 | $3.7B | $164.0M | ||
| Q3 24 | $3.8B | $139.4M | ||
| Q2 24 | $3.8B | $128.4M | ||
| Q1 24 | $3.9B | $126.5M |
负债/权益比BRSPRIGL
| Q4 25 | 2.63× | 0.13× | ||
| Q3 25 | 2.22× | 0.51× | ||
| Q2 25 | 2.27× | 0.73× | ||
| Q1 25 | 2.27× | 3.23× | ||
| Q4 24 | 2.38× | 18.25× | ||
| Q3 24 | 2.36× | — | ||
| Q2 24 | 2.28× | — | ||
| Q1 24 | 2.17× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $55.1M | — |
| 自由现金流率自由现金流/营收 | 66.2% | — |
| 资本支出强度资本支出/营收 | 21.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $102.0M | — |
8季度趋势，按日历期对齐
经营现金流BRSPRIGL
| Q4 25 | $73.0M | $22.0M | ||
| Q3 25 | $29.9M | $24.0M | ||
| Q2 25 | $17.4M | $30.5M | ||
| Q1 25 | $10.5M | $-893.0K | ||
| Q4 24 | $103.4M | $14.5M | ||
| Q3 24 | $31.3M | $21.7M | ||
| Q2 24 | $22.9M | $302.0K | ||
| Q1 24 | $24.6M | $-5.0M |
自由现金流BRSPRIGL
| Q4 25 | $55.1M | — | ||
| Q3 25 | $27.4M | — | ||
| Q2 25 | $11.6M | — | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $97.3M | — | ||
| Q3 24 | $28.3M | — | ||
| Q2 24 | $22.7M | — | ||
| Q1 24 | $22.2M | — |
自由现金流率BRSPRIGL
| Q4 25 | 66.2% | — | ||
| Q3 25 | 32.7% | — | ||
| Q2 25 | 13.4% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 116.6% | — | ||
| Q3 24 | 32.1% | — | ||
| Q2 24 | 24.9% | — | ||
| Q1 24 | 23.2% | — |
资本支出强度BRSPRIGL
| Q4 25 | 21.6% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 7.3% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 2.5% | — |
现金转化率BRSPRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 30.36× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 1.97× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 2.46× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
